No point banning Dishoom in Pak, it is a wrong decision: John and Varun | Bollywood - Hindustan Times
close_game
close_game

No point banning Dishoom in Pak, it is a wrong decision: John and Varun

ByANI, Mumbai
Aug 01, 2016 03:40 PM IST

After Varun Dhawan, his co-star John Abraham expressed disagreement over banning their latest outing Dishoom in Pakistan.

After Varun Dhawan, his co-star John Abraham expressed disagreement over banning their latest outing Dishoom in Pakistan. “I have told it even earlier that this film is not anti-Pakistan. Our antagonist in the film ‘Wagah’ is not someone from India or Pakistan. We have clearly said that in the film. So I don’t think there’s any point to ban the movie in Pakistan,” he said.

John Abraham and Varun Dhawan’s buddy-cop film Dishoom is mainly about flashy landscapes and elaborately planned action sequences.
John Abraham and Varun Dhawan’s buddy-cop film Dishoom is mainly about flashy landscapes and elaborately planned action sequences.

Read: Dishoom movie review

Hindustan Times - your fastest source for breaking news! Read now.

Varun, who is seen playing Junaid Ansari, took to Twitter on Saturday to post, “Really upset that ‘Dishoom’ is banned in Pakistan. I don’t think the film eventually shows any country in a bad light. It’s a wrong decision.”

The movie, which is getting a good response in the nation due to its masala-content, is about abduction of India’s top batsman Viraj before Indo-Pak match and two police officials from either side of the Arabian Sea team up for a 36-hour manhunt.

Read: Dishoom has Bollywood’s most expensive chase sequence

Follow @htshowbiz for more

Oscars 2024: From Nominees to Red Carpet Glam! Get Exclusive Coverage on HT. Click Here

Get more updates from Bollywood, Hollywood, Music and Web Series along with Latest Entertainment News at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On